235 related articles for article (PubMed ID: 8773153)
1. Proliferation of gemistocytic cells and glial fibrillary acidic protein (GFAP)-positive oligodendroglial cells in gliomas: a MIB-1/GFAP double labeling study.
Kros JM; Schouten WC; Janssen PJ; van der Kwast TH
Acta Neuropathol; 1996; 91(1):99-103. PubMed ID: 8773153
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas.
Kros JM; Van Eden CG; Stefanko SZ; Waayer-Van Batenburg M; van der Kwast TH
Cancer; 1990 Sep; 66(6):1204-12. PubMed ID: 2205356
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural characterization of transitional cells in oligodendrogliomas.
Kros JM; de Jong AA; van der Kwast TH
J Neuropathol Exp Neurol; 1992 Mar; 51(2):186-93. PubMed ID: 1538242
[TBL] [Abstract][Full Text] [Related]
4. Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma.
Herpers MJ; Budka H
Acta Neuropathol; 1984; 64(4):265-72. PubMed ID: 6391068
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural and immunohistochemical segregation of gemistocytic subsets.
Kros JM; Stefanko SZ; de Jong AA; van Vroonhoven CC; van der Heul RO; van der Kwast TH
Hum Pathol; 1991 Jan; 22(1):33-40. PubMed ID: 1985075
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological study of cellular proliferation and invasion in gliomatosis cerebri: important role of neural cell adhesion molecule L1 in tumour invasion.
Suzuki T; Izumoto S; Fujimoto Y; Maruno M; Ito Y; Yoshimine T
J Clin Pathol; 2005 Feb; 58(2):166-71. PubMed ID: 15677537
[TBL] [Abstract][Full Text] [Related]
7. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
Korshunov AG; Sycheva RV
Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
[TBL] [Abstract][Full Text] [Related]
8. Aberrant localization of the neuronal class III beta-tubulin in astrocytomas.
Katsetos CD; Del Valle L; Geddes JF; Assimakopoulou M; Legido A; Boyd JC; Balin B; Parikh NA; Maraziotis T; de Chadarevian JP; Varakis JN; Matsas R; Spano A; Frankfurter A; Herman MM; Khalili K
Arch Pathol Lab Med; 2001 May; 125(5):613-24. PubMed ID: 11300931
[TBL] [Abstract][Full Text] [Related]
9. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
Heesters MA; Koudstaal J; Go KG; Molenaar WM
J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
[TBL] [Abstract][Full Text] [Related]
10. Biological behavior and tumorigenesis of subependymal giant cell astrocytomas.
Kim SK; Wang KC; Cho BK; Jung HW; Lee YJ; Chung YS; Lee JY; Park SH; Kim YM; Choe G; Chi JG
J Neurooncol; 2001 May; 52(3):217-25. PubMed ID: 11519851
[TBL] [Abstract][Full Text] [Related]
11. [Importance of immunohistochemistry for neuro-oncology. III. Demonstration of glial fibrillary acidic proteins (GFAP) in anaplastic astrocytomas and glioblastomas].
Martin H; Gottschalk J; Hufnagl P; Szymaś J
Zentralbl Allg Pathol; 1986; 132(3):209-14. PubMed ID: 3538706
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic characteristics of GFAP-immunopositive oligodendroglial tumours Part I: immunohistochemical study.
Matyja E; Taraszewska A; Zabek M
Folia Neuropathol; 2001; 39(1):19-26. PubMed ID: 11678347
[TBL] [Abstract][Full Text] [Related]
13. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.
Rousseau A; Nutt CL; Betensky RA; Iafrate AJ; Han M; Ligon KL; Rowitch DH; Louis DN
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1149-56. PubMed ID: 17146289
[TBL] [Abstract][Full Text] [Related]
14. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
Reyaz N; Tayyab M; Khan SA; Siddique T
J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
[TBL] [Abstract][Full Text] [Related]
15. [Significance of immunohistochemistry for neuro-oncology. VI. Occurrence, localization and distribution of glial fibrillary acid protein (GFAP) in 820 tumors].
Gottschalk J; Szymaś J
Zentralbl Allg Pathol; 1987; 133(4):319-30. PubMed ID: 3425011
[TBL] [Abstract][Full Text] [Related]
16. [An immunohistochemical and ultrastructural study of 243 gliomas with reference to the prognosis].
Bian XW
Zhonghua Bing Li Xue Za Zhi; 1992 Jun; 21(3):171-3. PubMed ID: 1335846
[TBL] [Abstract][Full Text] [Related]
17. GFAP-positive neoplastic astrocytes in spontaneous oligodendrogliomas and mixed gliomas of rats.
Nagatani M; Yamakawa S; Saito T; Ando R; Hoshiya T; Tamura K; Uchida K
Toxicol Pathol; 2013; 41(4):653-61. PubMed ID: 23076037
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical study of S-phase cells in human gliomas].
Ibayashi N; Hirakawa K; Suzuki K; Nakamura K; Houri T
No To Shinkei; 1988 Aug; 40(8):763-9. PubMed ID: 2460117
[TBL] [Abstract][Full Text] [Related]
20. Glial fibrillary acidic protein and its fragments discriminate astrocytoma from oligodendroglioma.
Luider TM; Kros JM; Sillevis Smitt PA; van den Bent MJ; Vecht CJ
Electrophoresis; 1999; 20(4-5):1087-91. PubMed ID: 10344289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
